66 related articles for article (PubMed ID: 179927)
21. Effects of somatostatin on insulin and glucagon in patients with insulinoma.
Fallucca F; Mirabella C; Tamburrano G; Gambardella S; Aufieri G; Barbetti F; Andreani D
J Endocrinol Invest; 1979; 2(3):257-60. PubMed ID: 231062
[TBL] [Abstract][Full Text] [Related]
22. [Intravenous injections of glucose, insulin and tolbutamide in healthy persons, diabetics, cirrhotics, and patients with insuloma (together with a contribution on the diagnostic value of the tolbutamide tests)].
CREUTZFELDT W; WILLE K; KAUP H
Dtsch Med Wochenschr; 1962 Oct; 87():2189-95. PubMed ID: 14023822
[No Abstract] [Full Text] [Related]
23. An islet cell carcinoma containing glucagon and insulin. Chronic glucagon excess and glucose homeostasis.
Boden G; Owen OE; Rezvani I; Elfenbein BI; Quickel KE
Diabetes; 1977 Feb; 26(2):128-37. PubMed ID: 190071
[TBL] [Abstract][Full Text] [Related]
24. Carbohydrate metabolism and pancreatic islet-cell function in thalassemia major.
Costin G; Kogut MD; Hyman C; Ortega JA
Diabetes; 1977 Mar; 26(3):230-40. PubMed ID: 320076
[TBL] [Abstract][Full Text] [Related]
25. Response of plasma insulin to small doses of tolbutamide in obesity and acromegaly.
Pelkonen R; Taskinen MR; Nikkilä EA
Int J Obes; 1977; 1(4):315-24. PubMed ID: 617112
[TBL] [Abstract][Full Text] [Related]
26. Serum and pancreatic immunoreactive insulin (IRI) and proinsulin-like component (PLC), serum IRI and PLC response to different stimuli in normal subjects and organic hyperinsulinism.
Rastogi GK; Sialy R; Sinha MK; Dash R; Chopra JS; Kataria RN
Acta Diabetol Lat; 1975; 12(5-6):309-23. PubMed ID: 181932
[TBL] [Abstract][Full Text] [Related]
27. Effects of secretin on the normal and pathological beta-cell.
Glaser B; Shapiro B; Glowniak J; Fajans SS; Vinik AI
J Clin Endocrinol Metab; 1988 Jun; 66(6):1138-43. PubMed ID: 2836469
[TBL] [Abstract][Full Text] [Related]
28. Glucagon test for insulinoma: a chemical study in 25 cases.
Marks V; Samols E
J Clin Pathol; 1968 May; 21(3):346-52. PubMed ID: 4301688
[TBL] [Abstract][Full Text] [Related]
29. Nonautonomous function of a pancreatic insulinoma.
Rayfield EJ; Pulini M; Golub A; Rubenstein AH; Horwitz DL
J Clin Endocrinol Metab; 1976 Dec; 43(6):1307-11. PubMed ID: 187613
[TBL] [Abstract][Full Text] [Related]
30. Plasma glucagon response to blood glucose fall, gastrointestinal hormones and arginine in man.
Oneda A; Sato M; Matsuda K; Yanbe A; Maruhama Y
Tohoku J Exp Med; 1972 Jul; 107(3):241-51. PubMed ID: 4639665
[No Abstract] [Full Text] [Related]
31. Insulin response to glucose or glucagon in subclinical diabetes previously injected with tolbutamide.
Ohneda A; Watanabe K; Maruhama Y; Itabashi H; Horigome K
Tohoku J Exp Med; 1977 Jan; 121(1):27-32. PubMed ID: 835136
[TBL] [Abstract][Full Text] [Related]
32. A familial glucagonoma syndrome: genetic, clinical and biochemical features.
Stacpoole PW; Jaspan J; Kasselberg AG; Halter SA; Polonsky K; Gluck FW; Liljenquist JE; Rabin D
Am J Med; 1981 May; 70(5):1017-26. PubMed ID: 6112877
[TBL] [Abstract][Full Text] [Related]
33. The glucagonoma syndrome: stimulus-induced plasma responses of circulating glucagon components IRG9000 and IRG3500.
Hendriks T; Jansen JB; van Tongeren JH
Acta Endocrinol (Copenh); 1984 Feb; 105(2):226-32. PubMed ID: 6141691
[TBL] [Abstract][Full Text] [Related]
34. A malignant insulinoma transformed into a glucagonoma syndrome.
Ohneda A; Otsuki M; Fujiya H; Yaginuma N; Kokubo T; Ohtani H
Diabetes; 1979 Nov; 28(11):962-9. PubMed ID: 226443
[No Abstract] [Full Text] [Related]
35. A case with glucagonoma syndrome--endocrine and metabolic studies.
Fukushima H; Yamaguchi K; Uzawa H; Kitoh M; Takemiya M; Konno T
Endocrinol Jpn; 1981 Apr; 28(2):111-25. PubMed ID: 6273136
[TBL] [Abstract][Full Text] [Related]
36. Effects of caerulein and pancreozymin on insulin secretion in normal subjects and in patients with insuloma.
Fallucca F; Carratù R; Tamburrano G; Javicoli M; Menzinger G; Andreani D
Horm Metab Res; 1972 Jan; 4(1):55. PubMed ID: 4551706
[No Abstract] [Full Text] [Related]
37. Plasma insulin: fluctuations in the "big" insulin component in man after glucose and other stimuli.
Gorden P; Roth J
J Clin Invest; 1969 Dec; 48(12):2225-34. PubMed ID: 4311236
[TBL] [Abstract][Full Text] [Related]
38. Insulinopenia in impaired glucose tolerance preservation of insulin response to I.V. arginine and tolbutamide.
Monson JP; Borthwick LJ; Spathis GS; Bloom SR
Acta Diabetol Lat; 1980; 17(1):1-7. PubMed ID: 6998240
[TBL] [Abstract][Full Text] [Related]
39. A case with glucagonoma syndrome--heterogeneity of glucagon and insulin.
Fukushima H; Yamaguchi K; Uzawa H
Endocrinol Jpn; 1981 Oct; 28(5):575-82. PubMed ID: 6284494
[TBL] [Abstract][Full Text] [Related]
40. Impaired alpha cell function in conditions with cortisol deficiency.
Fallucca F; Gambardella S; Tamburrano G; Spallone V; Napoli A; Menzinger G
J Endocrinol Invest; 1980; 3(3):263-5. PubMed ID: 7000877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
